Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 25 studies | 25% ± 8% | |
endothelial cell of lymphatic vessel | 19 studies | 33% ± 13% | |
fibroblast | 13 studies | 21% ± 9% | |
vein endothelial cell | 10 studies | 25% ± 7% | |
retinal rod cell | 8 studies | 26% ± 13% | |
endothelial cell of vascular tree | 7 studies | 20% ± 3% | |
glutamatergic neuron | 6 studies | 31% ± 20% | |
epithelial cell | 6 studies | 25% ± 6% | |
Mueller cell | 5 studies | 34% ± 10% | |
CD16-negative, CD56-bright natural killer cell, human | 4 studies | 17% ± 2% | |
capillary endothelial cell | 4 studies | 19% ± 3% | |
retinal pigment epithelial cell | 4 studies | 31% ± 11% | |
lymphocyte | 4 studies | 30% ± 11% | |
natural killer cell | 3 studies | 21% ± 6% | |
T cell | 3 studies | 16% ± 1% | |
transit amplifying cell | 3 studies | 26% ± 10% | |
astrocyte | 3 studies | 32% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3545.46 | 1445 / 1445 | 100% | 22.38 | 183 / 183 |
prostate | 100% | 3996.14 | 245 / 245 | 100% | 19.31 | 502 / 502 |
lung | 100% | 4169.39 | 578 / 578 | 100% | 14.42 | 1152 / 1155 |
intestine | 100% | 3018.52 | 966 / 966 | 99% | 12.71 | 524 / 527 |
thymus | 100% | 5513.30 | 653 / 653 | 99% | 18.95 | 599 / 605 |
stomach | 100% | 2361.09 | 359 / 359 | 99% | 15.06 | 283 / 286 |
breast | 100% | 4497.55 | 459 / 459 | 99% | 13.35 | 1104 / 1118 |
bladder | 100% | 4210.90 | 21 / 21 | 99% | 12.95 | 497 / 504 |
kidney | 100% | 2470.66 | 89 / 89 | 98% | 13.80 | 886 / 901 |
uterus | 100% | 5253.65 | 170 / 170 | 98% | 13.64 | 451 / 459 |
ovary | 100% | 2910.88 | 180 / 180 | 98% | 11.15 | 422 / 430 |
skin | 100% | 4440.75 | 1809 / 1809 | 96% | 18.16 | 453 / 472 |
pancreas | 95% | 1099.70 | 312 / 328 | 98% | 12.50 | 174 / 178 |
adrenal gland | 100% | 2409.75 | 258 / 258 | 92% | 8.50 | 212 / 230 |
brain | 83% | 962.71 | 2203 / 2642 | 98% | 7.91 | 689 / 705 |
liver | 74% | 688.80 | 168 / 226 | 61% | 3.63 | 248 / 406 |
adipose | 100% | 4999.00 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3692.38 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 2457.59 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.61 | 1 / 1 |
muscle | 99% | 1536.61 | 796 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 13.14 | 44 / 45 |
heart | 91% | 1406.47 | 786 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 84% | 1346.22 | 782 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 84% | 7.09 | 67 / 80 |
lymph node | 0% | 0 | 0 / 0 | 83% | 7.14 | 24 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0005874 | Cellular component | microtubule |
GO_0030658 | Cellular component | transport vesicle membrane |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005622 | Cellular component | intracellular anatomical structure |
GO_0045202 | Cellular component | synapse |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0016010 | Cellular component | dystrophin-associated glycoprotein complex |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005925 | Cellular component | focal adhesion |
GO_0003779 | Molecular function | actin binding |
GO_0005516 | Molecular function | calmodulin binding |
GO_0005515 | Molecular function | protein binding |
GO_0005198 | Molecular function | structural molecule activity |
GO_0003723 | Molecular function | RNA binding |
Gene name | SNTB2 |
Protein name | Syntrophin beta 2 Beta-2-syntrophin Alternative protein SNTB2 Beta-2-syntrophin (59 kDa dystrophin-associated protein A1 basic component 2) (Syntrophin-3) (SNT3) (Syntrophin-like) (SNTL) |
Synonyms | SNTL SNT2B2 D16S2531E |
Description | FUNCTION: Adapter protein that binds to and probably organizes the subcellular localization of a variety of membrane proteins. May link various receptors to the actin cytoskeleton and the dystrophin glycoprotein complex. May play a role in the regulation of secretory granules via its interaction with PTPRN. |
Accessions | ENST00000613835.2 L8EAJ4 J3KT21 ENST00000524887.5 ENST00000571655.2 ENST00000467311.5 [Q13425-2] H7BY41 A0A0G2JLB8 Q13425 ENST00000574270.4 H0YCS0 ENST00000360496.5 ENST00000525632.5 ENST00000336278.9 [Q13425-1] A0A140TA73 A0A0G2JM75 ENST00000577080.2 ENST00000571496.2 |